WGS Q2 2022 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q2 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$36M-23.1% YoY

Gross Profit

-$30M-81.8% margin

Operating Income

-$163M-449.7% margin

Net Income

-$86M-237.1% margin

EPS (Diluted)

$-8.38

QoQ Revenue Growth

-32.9%

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$88M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$933M

Total Liabilities

$296M

Stockholders' Equity

$637M

Cash & Equivalents

$285M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$47M	-23.1%
Gross Profit	-$30M	-$1M	-2442.8%
Operating Income	-$163M	-$45M	-257.9%
Net Income	-$86M	-$46M	-85.7%

Revenue Segments

Diagnostic Test

$34M48%

Diagnostic Test, Third Party Insurance

$21M30%

Diagnostic Test, Institutional Customers

$11M16%

Product and Service, Other

$2M3%

Diagnostic Test, Self Pay

$1M2%